Medicine
Volume 36, Issue 7 , Pages 339-343 , July 2008

Clinical pharmacology: the basics

References 

  1. Bräuner-Osborne H, Wellendorph P, Jensen AA. Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors. Curr Drug Targets. 2007;8:169–184
  2. Sanders RD, Brian D, Maze M. G-protein-coupled receptors. Handb Exp Pharmacol. 2008;182:93–117
  3. Hollmann MW, Strumper D, Herroeder S, Durieux ME. Receptors, G proteins, and their interactions. Anesthesiology. 2005;103:1066–1078
  4. Roberts DM, Buckley NA. Pharmacokinetic considerations in clinical toxicology: clinical applications. Clin Pharmacokinet. 2007;46:897–939
  5. Dingemanse J, Appel-Dingemanse S. Integrated pharmacokinetics and pharmacodynamics in drug development. Clin Pharmacokinet. 2007;46:713–737
  6. Bertilsson L. Metabolism of antidepressant and neuroleptic drugs by cytochrome p450s: clinical and interethnic aspects. Clin Pharmacol Ther. 2007;82:606–609
  7. Lanfear DE, McLeod HL. Pharmacogenetics: using DNA to optimize drug therapy. Am Fam Physician. 2007;76:1179–1182
  8. Baudhuin LM, Langman LJ, O’Kane DJ. Translation of pharmacogenetics into clinically relevant testing modalities. Clin Pharmacol Ther. 2007;82:373–376
  9. Ross CJ, Katzov H, Carleton B, Hayden MR. Pharmacogenomics and its implications for autoimmune disease. J Autoimmun. 2007;28:122–128
  10. Lunshof JE, Pirmohamed M, Gurwitz D. Personalized medicine: decades away?. Pharmacogenomics. 2006;7:237–241
  11. Pirmohamed M, Breckenridge AM, Kitteringham NR, Park BK. Adverse drug reactions. BMJ. 1998;316:1295–1298
  12. Pirmohamed M, Park BK. Adverse drug reactions: back to the future. Br J Clin Pharmacol. 2003;55:486–492
  13. Meyboom RH, Egberts AC, Edwards IR, Hekster YA, de Koning FH, Gribnau FW. Principles of signal detection in pharmacovigilance. Drug Saf. 1997;16:355–365

PII: S1357-3039(08)00114-X

doi: 10.1016/j.mpmed.2008.04.005

Medicine
Volume 36, Issue 7 , Pages 339-343 , July 2008

Article Tools